Search Results
Updated results from the BRUIN study: pirtobrutinib in the treatment of MCL
Updated results of Phase I/II BRUIN study: pirtobrutinib in covalent BTK inhibitor pretreated MCL
BRUIN study cohort update: pirtobrutinib for patients with MCL
Updates from the BRUIN study – long-term safety of pirtobrutinib in R/R MCL
BRUIN study: updated two-year subgroup analysis of pirtobrutinib for BTKi pre-treated MCL
Updated results of the BRUIN trial: pirtobrutinib in R/R MCL
Efficacy of pirtobrutinib in patients with R/R MCL previously treated with a covalent BTKi
Updates from the Phase I/II BRUIN study: pirtobrutinib in CLL
Pirtobrutinib for BTK inhibitor-naïve and BTK inhibitor pre-treated R/R MCL
BRUIN study update: analysis of the mechanisms of resistance to pirtobrutinib in CLL
Latest updates from the Phase I/II BRUIN study
Phase I/II BRUIN study: pirtobrutinib in patients intolerant to a covalent BTK inhibitor
